Keycorp Stock News

KeyCorp (NYSE:KEY) shares, rose in value at last check on Thursday, 12/16/21, with the stock price up by 2.14% to the previous day’s close as strong demand from buyers drove the stock to $23.60. Actively observing the price movement in the recent trading, the stock is buoying the session at $23.11, falling within a range … What Makes KeyCorp (NYSE: KEY) One Of The Best Momentum Picks? Read More »

KeyCorp (NYSE:KEY) Equities research analysts at Piper Sandler upped their FY2022 earnings per share estimates for KeyCorp in a report issued on Tuesday, December 14th. Piper Sandler analyst R. Siefers now anticipates that the financial services provider will post earnings of $1.96 per share for the year, up from their prior estimate of $1.95. []

Shares of KeyCorp (NYSE: KEY) are up more than 40% this year, but BofA Securities says the stock will rally further in the coming months. Ebrahim Poonawala sees upside to $27 a share KEY received a do

Shares of KeyCorp (NYSE: KEY) are up more than 40% this year, but BofA Securities says the stock will rally further in the coming months. Ebrahim Poonawala sees upside to $27 a share KEY received a do

Moloney Securities Asset Management LLC lessened its stake in KeyCorp (NYSE:KEY) by 1.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,972 shares of the financial services providers stock after selling 1,050 shares during the quarter. Moloney Securities Asset Management []

Recent meetings with KeyCorp’s (NYSE: KEY) CEO Chris Gorman and CFO Don Kimble highlighted the company’s significant and differentiated growth potential, according to BofA Securities. The KeyC

The "Halftime Report" traders debate Bank of America's bullish call on KeyCorp.

Recent meetings with KeyCorp's (NYSE:KEY) CEO Chris Gorman and CFO Don Kimble highlighted the company's significant and differentiated growth potential, according to BofA Securities. The KeyCorp A

Quest Diagnostics Incorporated (NYSE:DGX) Analysts at KeyCorp lifted their FY2021 EPS estimates for shares of Quest Diagnostics in a report issued on Sunday, December 12th. KeyCorp analyst D. Hooker now anticipates that the medical research company will post earnings of $14.17 per share for the year, up from their previous forecast of $13.90. KeyCorp []

Meritage Portfolio Management decreased its stake in shares of KeyCorp (NYSE:KEY) by 0.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 174,024 shares of the financial services provider’s stock after selling 557 shares during the period. Meritage Portfolio Management’s […]

DekaBank Deutsche Girozentrale boosted its position in KeyCorp (NYSE:KEY) by 41.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 230,858 shares of the financial services provider’s stock after buying an additional 67,682 shares during the period. DekaBank Deutsche Girozentrale’s holdings in KeyCorp […]

Medical Properties Trust, Inc. (NYSE:MPW) – Equities research analysts at KeyCorp issued their Q1 2023 earnings per share (EPS) estimates for Medical Properties Trust in a report issued on Thursday, December 9th. KeyCorp analyst J. Sadler forecasts that the real estate investment trust will post earnings per share of $0.48 for the quarter. KeyCorp also […]

The trading price of KeyCorp (NYSE:KEY) floating lower at last check on Monday, December 13, closing at $22.64, -1.61% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

Laurel Road, a digital banking platform and a subsidiary of KeyBank, says that younger people are stressed about their finances, something that should come as no surprise as inflation goes through the roof and the federal government is on a spending spree. In a survey Read More